NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.90+0.08 (+9.83%)
Close on Nov 18, 2026Market cap $104.20MP/E –Yield –
NovaBridge Biosciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
NovaBridge Biosciences's revenue for the twelve months ending Dec 31, 2019 was CN¥30.00M. For fiscal 2023 it was CN¥27.64M. The highest annual figure on record is CN¥1.54B in fiscal 2020.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | CN¥27.64M | – |
| FY2022 | Dec 31, 2022 | -CN¥221.56M | -351.7% |
| FY2021 | Dec 31, 2021 | CN¥88.03M | -94.3% |
| FY2020 | Dec 31, 2020 | CN¥1.54B | +5042.2% |
| FY2019 | Dec 31, 2019 | CN¥30.00M | -44.2% |
| FY2018 | Dec 31, 2018 | CN¥53.78M | +365.4% |
| FY2017 | Dec 31, 2017 | CN¥11.56M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | CN¥0 | – |
See a number that looks wrong?